The board of The Biotech Growth Trust PLC has announced the appointment of Hamish Baillie as an independent non-executive director of the company, with effect from 1 November.
Baillie will join the company’s audit committee, management engagement committee, and nominations committee from the same date.
This time last year, Baillie retired from Ruffer LLP, where he had spent his executive career. He had joined Ruffer in 2002, becoming a partner in 2006 and, in 2011, lead manager of Ruffer Investment Company Ltd.
He founded and managed the Edinburgh office of Ruffer and held firm-wide responsibilities in relation to portfolio management and investor communications. He was a member of the firm’s UK wealth leadership team and a director of Ruffer (Channel Islands) Limited.
Baillie also serves as a NED of Mid Wynd International Investment Trust plc.
Roger Yates, chair of The Biotech Growth Trust, commented: “My fellow directors and I are delighted to welcome Hamish Baillie to the board. We are very pleased to have appointed a director with such extensive experience and expertise both in managing an investment trust and as a non-executive director. Hamish’s skillset complements the experience and skills of the rest of the board and we look forward to working together.”